Amgen Inc (NAS:AMGN)
$ 308.45 -1.7 (-0.55%) Market Cap: 165.46 Bil Enterprise Value: 220.69 Bil PE Ratio: 44.06 PB Ratio: 32.95 GF Score: 89/100

Amgen Inc at Jefferies Virtual London Healthcare Conference Transcript

Nov 18, 2020 / 05:00PM GMT
Release Date Price: $227.76 (-2.01%)
Michael Jonathan Yee
Jefferies LLC, Research Division - Equity Analyst

Good afternoon, everyone, and welcome to another great session here at the Jefferies Virtual London Healthcare Conference. I am here virtually in London right behind me, and Peter was just saying that he used to work there as well, so we had a good laugh about that. And hopefully, in 2021, we'll be back there in person.

I wanted to introduce my wonderful colleagues and friends here. You know them, Executive Vice President and CFO of Amgen, Peter Griffith on there with us. And everybody knows Head of Investor Relations, Arvind Sood, with us as well.

Questions & Answers

Michael Jonathan Yee
Jefferies LLC, Research Division - Equity Analyst

I guess I just wanted to take a step back for Peter. Maybe, Peter, 2020, I guess, people like to overuse the word unprecedented year, but it was truly a unique year. And Amgen, I think, has done a pretty good job of managing through the pandemic.

So maybe just make a statement first about your state of the affairs for 2020 and

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot